New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Potential noninvasive test for Alzheimer's disease

Potential noninvasive test for Alzheimer's disease

by University of Central LancashireProfessor Francis Martin, principal investigator of the study and Biosciences theme lead at UCLan. Credit: University of Central LancashireIn the largest and most co
Neurology April 07,2024
Potential noninvasive test for Alzheimer's disease

Potential noninvasive test for Alzheimer's disease

by University of Central LancashireProfessor Francis Martin, principal investigator of the study and Biosciences theme lead at UCLan. Credit: University of Central LancashireIn the largest and most co
Neurology April 07,2024
New imaging technique in Alzheimer's disease opens up possibilities for drug development

New imaging technique in Alzheimer's disease opens up possibilities for drug development

by Lund UniversityThe brain of an Alzheimer’s patient in a tau PET image. Red indicates the areas with the highest concentration of the tau protein. In the magnifying glass, a microscope enlargem
Neurology April 07,2024
New imaging technique in Alzheimer's disease opens up possibilities for drug development

New imaging technique in Alzheimer's disease opens up possibilities for drug development

by Lund UniversityThe brain of an Alzheimer’s patient in a tau PET image. Red indicates the areas with the highest concentration of the tau protein. In the magnifying glass, a microscope enlargem
Neurology April 07,2024
The molecular mechanisms of Alzheimer's

The molecular mechanisms of Alzheimer's

by Pacific Northwest National LaboratoryFigure 1 in the paper outlines the quantitative proteomic pipeline for O-GlcNAc analysis. stochastic kinetic simulations (red) and simulations using the co
Neurology April 07,2024
The molecular mechanisms of Alzheimer's

The molecular mechanisms of Alzheimer's

by Pacific Northwest National LaboratoryFigure 1 in the paper outlines the quantitative proteomic pipeline for O-GlcNAc analysis. stochastic kinetic simulations (red) and simulations using the co
Neurology April 07,2024
Researchers identify enzyme linked to colitis

Researchers identify enzyme linked to colitis

by Rutgers UniversityEndoscopic image of a bowel section known as the sigmoid colon afflicted with ulcerative colitis. The internal surface of the colon is blotchy and broken in places. Credit: S
Gastroenterology April 07,2024
Researchers identify enzyme linked to colitis

Researchers identify enzyme linked to colitis

by Rutgers UniversityEndoscopic image of a bowel section known as the sigmoid colon afflicted with ulcerative colitis. The internal surface of the colon is blotchy and broken in places. Credit: S
Gastroenterology April 07,2024
Researchers discover new drug target for inflammatory bowel disease

Researchers discover new drug target for inflammatory bowel disease

by UT Southwestern Medical CenterColonoscopic image of mice lacking the Pak2 gene showing severe colon inflammation. Credit: UT Southwestern Medical centerA set of interacting molecules in immune
Gastroenterology April 07,2024
Researchers discover new drug target for inflammatory bowel disease

Researchers discover new drug target for inflammatory bowel disease

by UT Southwestern Medical CenterColonoscopic image of mice lacking the Pak2 gene showing severe colon inflammation. Credit: UT Southwestern Medical centerA set of interacting molecules in immune
Gastroenterology April 07,2024
Researchers unveil mechanisms to prevent Crohn's disease

Researchers unveil mechanisms to prevent Crohn's disease

by The Mount Sinai HospitalHigh magnification micrograph of Crohn's disease. Biopsy of esophagus. H&E stain. Credit: Nephron/WikipediaIn a series of four studies published today inG
Gastroenterology April 07,2024
Researchers unveil mechanisms to prevent Crohn's disease

Researchers unveil mechanisms to prevent Crohn's disease

by The Mount Sinai HospitalHigh magnification micrograph of Crohn's disease. Biopsy of esophagus. H&E stain. Credit: Nephron/WikipediaIn a series of four studies published today inG
Gastroenterology April 07,2024
Researchers identify bacterial protein associated with colorectal cancers

Researchers identify bacterial protein associated with colorectal cancers

by Johns Hopkins University Bloomberg School of Public HealthCredit: Johns Hopkins University Bloomberg School of Public HealthStrains of bacteria that cause common food-poisoning symptoms often
Gastroenterology April 07,2024
Researchers identify bacterial protein associated with colorectal cancers

Researchers identify bacterial protein associated with colorectal cancers

by Johns Hopkins University Bloomberg School of Public HealthCredit: Johns Hopkins University Bloomberg School of Public HealthStrains of bacteria that cause common food-poisoning symptoms often
Gastroenterology April 07,2024
Researchers develop gut-restricted drug to treat inflammatory bowel disease

Researchers develop gut-restricted drug to treat inflammatory bowel disease

by Johns Hopkins University School of MedicineImages on the right are of normal human gut without IBD. Left side images show the dramatic increase of the GCPII protein in humans with IBD. Credit:
Gastroenterology April 07,2024
Researchers develop gut-restricted drug to treat inflammatory bowel disease

Researchers develop gut-restricted drug to treat inflammatory bowel disease

by Johns Hopkins University School of MedicineImages on the right are of normal human gut without IBD. Left side images show the dramatic increase of the GCPII protein in humans with IBD. Credit:
Gastroenterology April 07,2024
Researchers determine bariatric surgery lowers health risks for people with common liver disorder

Researchers determine bariatric surgery lowers health risks for people with common liver disorder

by West Virginia UniversityBariatric surgery—or gastric bypass—as a treatment method for patients with nonalcoholic fatty liver disease has a significant impact on improving clinical outcomes, a
Gastroenterology April 07,2024
Researchers determine bariatric surgery lowers health risks for people with common liver disorder

Researchers determine bariatric surgery lowers health risks for people with common liver disorder

by West Virginia UniversityBariatric surgery—or gastric bypass—as a treatment method for patients with nonalcoholic fatty liver disease has a significant impact on improving clinical outcomes, a
Gastroenterology April 07,2024
Researchers identify driver of inflammatory bowel disease

Researchers identify driver of inflammatory bowel disease

by UT Southwestern Medical CenterRaftlin1 recruits phospholipids to RORγt and promotes the pathogenicity of Th17 cells. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-406
Gastroenterology April 07,2024
Researchers identify driver of inflammatory bowel disease

Researchers identify driver of inflammatory bowel disease

by UT Southwestern Medical CenterRaftlin1 recruits phospholipids to RORγt and promotes the pathogenicity of Th17 cells. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-406
Gastroenterology April 07,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com